Physician profile

Daniel Paul Williams

Emergency Medicine · Buffalo, NY

NPI 1740675750

$1,489.10

in general payments reported to CMS, 2019-2025

5 companies · $1,489 in 2025

The $1,489 reported for 2025 was more than what 96% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).

See the full distribution for Emergency Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$855.46
Food and Beverage$633.64

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novartis Pharmaceuticals Corporation $773.76 2025
Merck Sharp & Dohme LLC $715.34 2025

3 companies reported research payments only; those appear in the research section below.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daniel Paul Williams

$1,489.10

in general payments reported 2019-2025

Years
2025
Top company
Novartis Pharmaceuticals Corporation
Context
The $1,489 reported for 2025 was more than what 96% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).

https://glasscript.com/doctor/5090006/daniel-paul-williams

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Download CSV

The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.